A Prospective Multicenter Observational Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms DIVA
- Sponsors Janssen
- 12 Dec 2017 Results (n=130) of two observational studies (DIVA and DRAMA) assessing overall survival, presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
- 30 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.